Krook A, Kumar S, Laing I, Boulton A J, Wass J A, O'Rahilly S
Department of Medicine, Addenbrooke's Hospital, University of Cambridge, United Kingdom.
Diabetes. 1994 Mar;43(3):357-68. doi: 10.2337/diab.43.3.357.
Using the molecular scanning technique of single-stranded conformational polymorphism (SSCP), we have examined the exons encoding the insulin receptor gene in 26 patients with syndromes of insulin resistance. We found 27 variant sequences, 4 of which were mutations that altered an amino acid. One patient with the Rabson-Mendenhall syndrome was homozygous for a mutation in the extracellular alpha-subunit (Ser to Leu323), one type A insulin-resistant patient was heterozygous for Pro to Leu1178, and another type A insulin-resistant patient was heterozygous for a mutation in the COOH-terminus of the receptor (Arg to Gln1351). The previously reported, and probably functionally insignificant, variant Val to Met985 was detected in one patient. No missense or nonsense insulin receptor mutations were found in any patients whose insulin resistance was associated with gross obesity, lipoatrophy, or acromegaloid features. No missense or nonsense mutations were found in subjects with polycystic ovary syndrome or Syndrome X. Putting these findings in the context of other work in this field, we conclude that subjects with leprechaunism or Rabson-Mendenhall syndrome have a high probability of having a missense or nonsense insulin receptor mutation. Nonobese, nondysmorphic, severely insulin-resistant females with hirsutism, acanthosis nigricans, and menstrual disturbance (type A phenotype) have an intermediate probability of having this type of insulin receptor mutation. Although insulin receptor mutations have been occasionally described in other phenotypes of insulin resistance, the frequency of point mutations in the exons of the insulin receptor gene in patients with those phenotypes appears to be low.
我们运用单链构象多态性(SSCP)分子扫描技术,检测了26例胰岛素抵抗综合征患者胰岛素受体基因的外显子。我们发现了27个变异序列,其中4个是改变氨基酸的突变。1例患有拉布森 - 门登霍尔综合征的患者在细胞外α亚基存在纯合突变(Ser变为Leu323),1例A型胰岛素抵抗患者在Pro1178处为杂合突变,另1例A型胰岛素抵抗患者在受体的COOH末端存在杂合突变(Arg变为Gln1351)。在1例患者中检测到了先前报道的、可能功能无显著意义的Val985变为Met的变异。在胰岛素抵抗与严重肥胖、脂肪萎缩或肢端肥大样特征相关的任何患者中,均未发现错义或无义胰岛素受体突变。在多囊卵巢综合征或X综合征患者中也未发现错义或无义突变。结合该领域的其他研究成果,我们得出结论:妖精貌综合征或拉布森 - 门登霍尔综合征患者很可能存在错义或无义胰岛素受体突变。非肥胖、无畸形、严重胰岛素抵抗且伴有多毛症、黑棘皮病和月经紊乱的女性(A型表型)具有中等概率存在此类胰岛素受体突变。尽管在其他胰岛素抵抗表型中偶尔也有胰岛素受体突变的描述,但具有这些表型的患者中胰岛素受体基因外显子点突变的频率似乎较低。